Composition
L-Ornithine L-Aspartate Injection
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Lolaberg IV contains LOLA (L-Ornithine L-Aspartate), which enhances hepatic ammonia detoxification by stimulating the urea cycle and glutamine synthesis.
Indication
Hepatic encephalopathy, hyperammonaemia, and as adjunctive therapy in chronic liver disease.
Packaging
Single vial pack
Storage
Store below 25°C, protected from light. Use reconstituted solution as directed.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.